Hum immunodeficiency virus type 1 expresses struct proteins and replicative enzymes within gag and gag-pol precursor polyproteins. Specific proteolytic processing of the precursors by the viral proteinase is essential for maturation of infectious viral particles. We have studied the activity of proteinase in its immature form, as part of a gag-pot fusion protein, in an in vitro expression system. We found that deletion of p6*, the region in po up m of proteinase, resulted in improved processing of the precursor. A modified proteinase is released, but it functions less ecen than wild type. Improved autoprocessing correlates with increased accessibility of the active site region in the polyprotein carrying the p6* deletion. Our results suggest that p6* is involved in the regulation of proteinase activation, perhaps as a region Umiting
activity of proteinase in its immature form, as part of a gag-pot fusion protein, in an in vitro expression system. We found that deletion of p6*, the region in po up m of proteinase, resulted in improved processing of the precursor. A modified proteinase is released, but it functions less ecen than wild type. Improved autoprocessing correlates with increased accessibility of the active site region in the polyprotein carrying the p6* deletion. Our results suggest that p6* is involved in the regulation of proteinase activation, perhaps as a region Umiting the interaction of the active site and substrate binding domain with the remainder ofthe polyprotein. Release ofp6* inhIbiton may be an activation step necessary for infectious particle maturation.
Human immunodeficiency virus type 1 (HIV-1) encodes two precursor polyproteins, gag and gag-pol, which must be proteolytically processed to produce mature structural proteins [matrix (MA) , capsid (CA), nucleocapsid (NC), and p6] and replicative enzymes [proteinase (PR), reverse transcriptase (RT), and integrase (IN)] (1). Maturation of infectious particles requires accurate processing of more than 10 cleavage sites recognized by the virus-encoded PR (2) (3) (4) . Unlike substrates that are recognized by cellular proteases and proteinases encoded by nonretroviral RNA viruses, neither the amino acids constituting the scissile bond nor the flanking amino acids that interact with the PR binding cleft are identical in primary amino acid sequence (5, 6) . HIV-1 PR is encoded as an 11-kDa domain within the pol region of the gag-pol polyprotein (7) (8) (9) (10) . Sequence analysis (11) , mutational dissection (12) , and crystallographic studies (13, 14) of purified PR have shown that this enzyme is a member of a family of mammalian aspartic proteases. However, it encodes only half of a catalytic center (Asp-Thr-Gly). Furthermore, proteolytic activity is found in association with a 22-kDa protein. Thus, mature PR activity requires both the scission of the PR domain from the precursor polyprotein at virus-specific cleavage sites and the association oftwo monomers to form an enzymatically active dimer. It remains to be determined whether HIV-1 PR has enzymatic activity only as a mature dimer and by what mechanism its dimerization and maturation occurs, as no cellular proteinase has been identified that catalyzes the release of PR from the polyprotein.
Processing by HIV-1 PR is essential in the viral life cycle. Mutations that destroy the catalytic site result in absence of all processing of viral polyproteins and lead to budding of noninfectious particles (2) (3) (4) . Mutations that block processing at specific gag sites (i.e., Tyr-Pro or Leu-Ala) also result in production of noninfectious particles, with aberrant morphology (4) . Thus, proteolytic processing by HIV-1 PR appears to be intimately linked with morphogenesis. However, it is not known by what mechanism assembly, processing, and budding are coordinately regulated.
All known mammalian aspartic proteases are encoded as zymogens, which are activated after cleavage from an upstream regulatory region (15) . Frameshifting within the NC domain of the gag gene leads to the synthesis of a gag-pol polyprotein in which the proteins are ordered MA-CA-NCp6*-PR-RT-IN. The 68-amino-acid sequence, called p6*, encoded upstream from PR in the pol reading frame (16) , has no ascribed function. We report here a study of the participation of p6* in the regulation of PR activity. We find that deletion of p6* from the polyprotein improves proteolytic processing.
MATERIALS AND METHODS
Construction of Wild-Type (wt) and Mutant rai. The construction of the parent plasmid (pHIV-FSIII) has been described (9, 16) . Briefly, pHIV-FSIII was made by transferring nucleotides 221-2130 of the HIV cDNA (from BH10) (17) into pBS/KS' (Stratagene) (16 Expression in Vitro. Expression of this construct in vitro was performed as described (16) . After in vitro transcription using T7 polymerase, synthetic RNAs 5 ,ul of RRL was diluted 100-fold, and immunoprecipitation was done as described (16) .
Purification of PR Expressed in E. coli and Proteolytic Processing in Trans. Purification of PR and assay of activity in trans reactions was performed as described (16, 19) .
RESULTS
Deletion of p6*, the Region Upstream of PR, Improves Proteolytic Processing. To investigate whether the p6* domain exerted any effect on proteolytic processing, we constructed a mutant with a deletion of this region, called Ap6*. This mutant lacks all of p6* and also the C-terminal processing site in NC (Phe-Leu) and the N-terminal cleavage site of PR (Phe-Pro). However, it maintains an Asn-Phe site near the C terminus of NC. Expression of Ap6* should yield a polyprotein, which may be cleaved at the Asn-Phe site, resulting in a PR with a modified N terminus (Phe-Leu-Gly-Lys-PR, or FLGK-PR) that is two residues larger than authentic PR. 1, lane 2) was identical to that previously described (9, 16) . wt lysates characteristically contain residual full-length precursors, initiated at the first methionine residue (product a, precursor protein pr69), and molecules initiated internally at the second methionine residue (Met-142) and methionine residues further downstream (ref. 16 ; product c, pr50 and smaller, respectively). The identity of primary translation products was confirmed by translation of FS-DTG (Fig. 1,  lane 3) , which contains an inactivating mutation in the PR domain (16, 20) . The major products in wt lysates (Fig. 1, lane 2), MA-CA (product d, p41) and CA (product f, p24/25), were detected in expected amounts based on their content of
[35S]methionine. PR (product g, p1l) was obscured by hemoglobin in RRL lysates but was detected after immunoprecipitation (cf. Fig. 2 ). Antibody for detection of mature NC (p7) was not available. Mature MA and p6* have no methionine residues and, therefore, were not detectable. Translation of mRNA encoding polypeptide Ap6* (Fig. 1, lane 4) resulted in a pattern of synthesis and proteolytic processing that was similar to that obtained following translation of wt mRNA, with the exception that wt contained residual precursors and intermediates (products a and c) that were reduced or entirely absent in Ap6* (products a' and c'). The mutant produced mature CA (product f) and a new 18-kDa species (product e'), which was anti-PR reactive (see below). Eighteen kilodaltons is the calculated molecular mass of the NC and PR (NC-PR) fusion protein, which would be expected to accumulate if the Asn-Phe site were not efficiently utilized. Apparently, this site was not efficiently utilized under these conditions, since NC-PR was detected more readily than PR (band g in Fig. 2 3 as well as lanes 5 and 7) . Complete digestion of translation products with PR followed by immunoprecipitation with anti-PR indicated that wt and Ap6* lysates contained approximately the same amount of labeled PR (band g in Fig. 2, lanes 4 and 8) . Note that band g in Fig.  2 , lane 8 migrated more slowly than wt PR, possibly due to the N-terminal modification. We conclude that processing of the Ap6* precursor polyprotein is more efficient than wt.
To quantitate the higher efficiency of Ap6* processing relative to wt, translation was done over a range of RNA concentrations (50-200 nM), and the ratio of CA (x) to residual precursor (y) was calculated after densitometry of autoradiographs (Fig. 3) . Fig. 3 shows products obtained with increasing mRNA concentrations. Since some forms ofc' and d comigrate, the entire peak at y (a', c', and d) was taken as Ap6* precursor. By this criterion, deletion of p6* improved proteolytic processing -2-fold at 200 nM mRNA (Fig. 3 G and H) and 6-fold at 50 nM mRNA (Fig. 3 A and B) compared with wt. Interestingly, with increasing amounts of added mRNA, x/y increased slightly for wt up to 150 nM mRNA (Fig. 3 A, C , and E) but was dramatically decreased for Ap6* (Fig. 3 B, D, F , and H). For wt, an increase in mRNA concentration from 50 to 200 nM resulted in a 3-fold increase in precursor and a similar 2.5-fold increase in CA. In contrast, increasing Ap6* mRNA increased precursor by 5-fold and had little affect (-1.2-fold) on the amount of CA produced. These results suggest that wt and Ap6* differ in the underlying processing mechanism and that the mutation affected the initial cleavage event.
Activity of the Altered PR Produced by Ap6*. We investigated the possibility that improved processing by Ap6* was due to formation of an altered form of PR that was more active and/or more stable than wt PR. Two proteins containing PR sequences can be produced from Ap6*, NC-PR (product e') and FLGK-PR (product g). Their relative amounts are dependent on the efficiency of cleavage at the Asn-Phe site. Since NC-PR failed to autoprocess, or to be processed further by FLGK-PR in the lysate, it seemed unlikely that these products were efficient enzymes. To synthesize the processed forms of PR exclusively, we expressed Ap6* or FS-WT in E. coli, where we have previously demonstrated rapid and complete wt polyprotein processing with accumulation of mature PR (9, 21). We then directly compared the activities ofthe mutant and wt enzymes in trans assays ( Fig. 4; (Fig. 4A, lane 1) , it DTG uninduced cells carrying Ap6* (Fig. 4A, lanes 2 and 3) or FS (Fig. 4A, lane 4) , or incubated with lysates of induced cells 111111 i1l iI R carrying Ap6* (Fig. 4A, lanes 5-10) or FS (Fig. 4A, lanes   11-19) . The regions also exhibit the greatest similarity to the proenzyme fragment and are positioned by alignment near the activation cleavage sites in the proenzyme fragment (23) . The lack of strong sequence conservation makes it unlikely that specific residues in p6* are critical for interaction with PR. However, the similarities suggest that p6* may play an important structural role in regulation of PR activity.
DISCUSSION
The restriction of proteolytic processing of the gag-pol polyprotein prior to assembly and budding of the retrovirus particle is a major conundrum. We have shown that sequences upstream of those encoding mature PR can inhibit proteolytic processing in an in vitro translation/proteolytic processing system. Certainly, this inhibition is not complete, as processing occurs in wt constructs. Moreover, oUr constructs lacked the C portion of pol, including all of RT and IN. Definitive analysis of the contributions of various segments of'the polyprotein towards processing will require inclusion of these sequences. Nevertheless, the function of the p6* region in the gag-pol polyprotein may be solely to delay processing of newly formed polypeptide chains.
One explanation for improved processing by Ap6* is that this mutation affects autocatalysis. Improved processing upon removal of upstream sequences is a characteristic feature of the cellular homologues of HIV PR. In some (e.g., pepsinogen), the activation step is independent of the proenzyme concentration, suggesting an intramolecular activation process in which the precursor molecule cleaves itself. ' James and Sielecki (23) , in an elegant study of the crystal structure of the zymogen pepsinogen, proposed that upstream sequences bind near the active site of pepsin, rendering the binding cleft inaccessible to substrates. We demonstrated here that removal of p6* increased the accessibility of the active site and binding cleft in the PR domain of the polyprotein. Alignment of the proenzyme fragment of'pepsinogen and the p6* regions of HIV-1 and other lentiviruses provides'a basis for speculation that a functional similarity exists between these regions. p6* may function as a spacer region in the gag-pol precursor, between PR and distal domains containing Asp residues that can potentially interact with the catalytic Asp-25 in PR. The slow step in the wt activation cleavage may be a bimolecular interaction that requires alteration of the p6* spacer function. Deletion of p6* may permit PR-substrate interaction to take place more freely, resulting in improved processing.
Improved autocatalysis could also result in release of a more efficient altered enzyme. However, our results, including analyses in vitro, in trans assays with crude enzyme, and insertional mutagenesis of Ap6* to change the structure of the modified enzyme (data not 'shown), do not support this conclusion. Other 
